General form of registration statement for all companies including face-amount certificate companies

SHAREHOLDERS' EQUITY - Narrative (Details)

v3.22.4
SHAREHOLDERS' EQUITY - Narrative (Details)
1 Months Ended 12 Months Ended
Nov. 15, 2021
USD ($)
$ / shares
shares
Aug. 31, 2021
$ / shares
shares
Apr. 30, 2021
USD ($)
shares
Dec. 01, 2020
USD ($)
item
$ / shares
shares
Sep. 30, 2021
$ / shares
shares
Jun. 30, 2021
$ / shares
shares
Sep. 30, 2020
USD ($)
shares
Jul. 31, 2020
USD ($)
item
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Sep. 30, 2022
$ / shares
shares
Jun. 09, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Apr. 30, 2020
$ / shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                            
Common stock, shares authorized   900,000,000     900,000,000         180,000,000 180,000,000   900,000,000  
Common stock, par value (in dollars per share) | $ / shares   $ 0.001     $ 0.001         $ 0.001 $ 0.001   $ 0.001  
Common stock, shares issued                   12,918,866 18,512,605   11,275,788  
Common stock, shares outstanding                   12,918,866 18,512,605   11,275,788  
Common stock authorized after Reverse Share Split (shares)         180,000,000                  
Reverse stock split ratio   0.2     0.2                  
Fractional shares issued         0                  
Authorized amount of shares that can be issued by the company | $                 $ 300,000          
Shares issued 909,262     3,271,541   156,032   25,185            
Number Of Units Issued       3,271,541                    
Share price | $ / shares $ 6.19         $ 4.00                
Number of common stock that will be issued per unit       1         1          
Shares issue price | $ / shares $ 5.25     $ 3.20         $ 4.05          
Number of warrants that will be issued per unit       1         0.5          
Common share purchase warrants per unit       1               1    
Term of warrants       5 years               48 months    
Warrant exercise price (in dollars per share) | $ / shares       $ 3.90         $ 5.65     $ 7.55   $ 5.00
Proceeds from Issuance of Private Placement | $ $ 4,750,000     $ 9,500,000       $ 102,000            
Value of shares issued on settlement of employee compensation | $ $ 435,000                          
Number of surgeons who are majority owners | item               2            
Shares issued on settlement of accounts payable             10,000              
Accounts payable settled on issuance of common stock | $             $ 40,000              
Number of management members who participated in the financing | item       3                    
Number of independent members who participated in the financing | item       2                    
Outstanding principal | $                   $ 60,000        
Shares issued on conversion of debt                   13,384        
Amended Stock Option Plan                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                            
Number of shares authorized                   2,000,000        
Three Management Members And Two Independent Members                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                            
Shares issued       95,291                    
Sentry Neuromonitoring, LLC                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                            
Value of common stock issuable | $     $ 1,625,000                      
Common stock issuable     237,226                      
Held in escrow, Value | $     $ 650,000                      
Held in escrow, Shares     94,891                      
Common stock lock up period     12 months